LivaNova
Revenue: $1.01B
Market Cap: $17.B
Rank: 78

LivaNova has been going through some hard times recently. The London, UK-based company’s longtime CEO, Damien McDonald departed after several pipeline disappointments – which included scrapping its transcatheter mitral valve replacement. However, despite any recent difficulty, LivaNova’s prowess in the cardiovascular space cannot be understated. The firm is the result of Sorin and Cyberonics taking part in a merger valued at $2.7 billion. The merger took the cardiovascular market by storm.

Check out a complete listing of MD+DI's Top 100 Medical Device Companies.